Header

UZH-Logo

Maintenance Infos

Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome


Göhring, G; Michalova, K; et al; Betts, D (2010). Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome. Blood, 116(19):3766-3769.

Abstract

To identify cytogenetic risk factors predicting outcome in children with advanced myelodysplastic syndrome, overall survival of 192 children prospectively enrolled in European Working Group of Myelodysplastic Syndrome in Childhood studies was evaluated with regard to karyotypic complexity. Structurally complex constitutes a new definition of complex karyotype characterized by more than or equal to 3 chromosomal aberrations, including at least one structural aberration. Five-year overall survival in patients with more than or equal to 3 clonal aberrations, which were not structurally complex, did not differ from that observed in patients with normal karyotype. Cox regression analysis revealed the presence of a monosomal and structurally complex karyotype to be strongly associated with poor prognosis (hazard ratio = 4.6, P < .01). Notably, a structurally complex karyotype without a monosomy was associated with a very short 2-year overall survival probability of only 14% (hazard ratio = 14.5; P < .01). The presence of a structurally complex karyotype was the strongest independent prognostic marker predicting poor outcome in children with advanced myelodysplastic syndrome.

Abstract

To identify cytogenetic risk factors predicting outcome in children with advanced myelodysplastic syndrome, overall survival of 192 children prospectively enrolled in European Working Group of Myelodysplastic Syndrome in Childhood studies was evaluated with regard to karyotypic complexity. Structurally complex constitutes a new definition of complex karyotype characterized by more than or equal to 3 chromosomal aberrations, including at least one structural aberration. Five-year overall survival in patients with more than or equal to 3 clonal aberrations, which were not structurally complex, did not differ from that observed in patients with normal karyotype. Cox regression analysis revealed the presence of a monosomal and structurally complex karyotype to be strongly associated with poor prognosis (hazard ratio = 4.6, P < .01). Notably, a structurally complex karyotype without a monosomy was associated with a very short 2-year overall survival probability of only 14% (hazard ratio = 14.5; P < .01). The presence of a structurally complex karyotype was the strongest independent prognostic marker predicting poor outcome in children with advanced myelodysplastic syndrome.

Statistics

Citations

39 citations in Web of Science®
41 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

387 downloads since deposited on 21 Feb 2011
78 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2010
Deposited On:21 Feb 2011 14:16
Last Modified:21 Nov 2017 15:18
Publisher:American Society of Hematology
ISSN:0006-4971
Additional Information:This research was originally published in Blood 2010 Nov 11;116(19):3766-9. Epub 2010 Aug 27.. Copyright by the American Society of Hematology
Publisher DOI:https://doi.org/10.1182/blood-2010-04-280313
PubMed ID:20802024

Download